Skip to main content

Advertisement

SpringerLink
Log in

Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?

  • LETTER TO THE EDITOR
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • D'Antoni ML, Paul RH, Mitchell BI, Kohorn L, Fischer L, Walker M, Kallianpur KJ, Ogata-Arakaki D, Ndhlovu LC, Shikuma C (2018) Improved cognitive performance and reduced monocyte activation in virally suppressed chronic HIV after dual CCR2 and CCR5 antagonism. J Acquir Immune Defic Syndr 79:108–116

    Article  CAS  Google Scholar 

  • Division of HIV/AIDS Prevention NCfHA, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (2018) Pre-exposure prophylaxis (PrEP) for HIV prevention factsheet. In

  • Gates TM, Cysique LA, Siefried KJ, Chaganti J, Moffat KJ, Brew BJ (2016) Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. AIDS 30:591–600

    Article  CAS  Google Scholar 

  • Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu A, Frank I, Ho K, Santana J, Stekler JD, McCauley M, Mayer KH (2017) Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection in men who have sex with men (HPTN 069/ACTG A5305). J Infect Dis 215:238–246

    CAS  PubMed  Google Scholar 

  • Massud I, Aung W, Martin A, Bachman S, Mitchell J, Aubert R, Solomon Tsegaye T, Kersh E, Pau CP, Heneine W, Garcia-Lerma JG (2013) Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues. J Virol 87:8952–8961

    Article  CAS  Google Scholar 

  • Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, Paul R, Zhang G, Ho E, Hanks N, Nakamoto B, Shiramizu BT, Shikuma CM (2014) Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND). J NeuroVirol 20:571–582

    Article  CAS  Google Scholar 

  • Neff CP, Ndolo T, Tandon A, Habu Y, Akkina R (2010) Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. PLoS One 5:e15257

    Article  CAS  Google Scholar 

  • Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–150

    Article  CAS  Google Scholar 

  • Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, Suwanwela NC, Jagodzinski L, Michael N, Spudich S, van Griensven F, de Souza M, Kim J, Ananworanich J, Group RSS (2012) Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 206:275–282

    Article  CAS  Google Scholar 

  • Veselinovic M, Yang KH, LeCureux J, Sykes C, Remling-Mulder L, Kashuba ADM, Akkina R (2014) HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor tenofovir and entry inhibitor maraviroc in a humanized mouse model. Virology 464-465:253–263

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Tropical Medicine, Medical Microbiology, and Pharmacology; John A. Burns School of Medicine, University of Hawaii, 651 Ilalo St., Biosciences Building 325, Honolulu, HI, 96813, USA

    Joanna Kettlewell, Melissa Agsalda-Garcia & Bruce Shiramizu

  2. Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA

    Maya Barney

  3. Department of Molecular Biosciences and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA

    Robert Oda

  4. Department of Quantitative Health Sciences, John A. Burns School of Medicine Biostatistics Core Facility; John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA

    Chathura Siriwardhana

Authors
  1. Joanna Kettlewell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maya Barney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melissa Agsalda-Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chathura Siriwardhana
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bruce Shiramizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Shiramizu.

Ethics declarations

This study was approved by the University of Hawaii Institutional Review Board. Participants signed written consent forms for enrollment.

Conflict of Interest

No conflicts are reported.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kettlewell, J., Barney, M., Oda, R. et al. Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?. J Neuroimmune Pharmacol 15, 10–12 (2020). https://doi.org/10.1007/s11481-019-09898-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-019-09898-3

Search

Navigation